蛋白酶Nexin-1调控恶性肿瘤的分子机制

doi:10.3760/cma.j.issn.1673-422X.2014.02.001

摘要/Abstract

摘要： 蛋白酶Nexin-1（PN-1）是Serpin类超家族的重要一员，在人类胰腺癌、乳腺癌、结肠癌、睾丸癌等多种恶性肿瘤细胞中异常表达，通过抑制多种蛋白酶、细胞外信号激酶（ERK）信号通路，参与肿瘤细胞的增生、分化、凋亡、血管新生和浸润，在肿瘤的发生发展及转移中起促进作用。特别是在前列腺癌中，PN1通过抑制尿激酶纤溶酶原激活剂（uPA）、Hh信号通路以及与基质金属蛋白酶(MMP)9的相互作用，在肿瘤的发生发展及转移中起抑制作用。

关键词: 细胞凋亡, 肿瘤转移, 肿瘤侵润, 蛋白酶Nexin-1

Abstract: Protease nexin-1 (PN-1) is one of the most important members of Serpin superfamily. The abnormal expressions are observed in many human cancers, such as pancreatic cancer, breast cancer, colon cancer, testicular cancer and so on. PN1 participates in tumor cell proliferation, differentiation, apoptosis, angiogenesis and invasion by inhibiting multiple proteases and extracellular signal regulated kinase (ERK) pathways and promotes tumor occurrence, development and metastasis. In prostate cancer particularly, PN1 inhibits tumor occurrence, development and metastasis by inhibiting urokinase plasminogen activator (uPA), Hh signaling pathway and interacting with matrix metalloproteinase (MMP)-9.

Key words: Apoptosis, Neoplasm metastasis, Neoplasm invasiveness, Protease nexin-1

辛向可, 徐丹梅. 蛋白酶Nexin-1调控恶性肿瘤的分子机制[J]. 国际肿瘤学杂志, 2014, 41(2): 81-84.

Xin Xiangke, Xu Danmei. Molecular mechanisms of protease Nexin-1 on regulating tumorgenesis[J]. Journal of International Oncology, 2014, 41(2): 81-84.

参考文献

［1］ Boulaftali Y, Adam F, Venisse L, et al. Anticoagulant and antithrombotic properties of platelet protease nexin1［J］. Blood, 2010, 115(1): 97106. ［2］ Bouton MC, Boulaftali Y, Richard B, et al. Emerging role of serpinE2/protease nexin1 in hemostasis and vascular biology［J］. Blood, 2012, 119(11): 24522457. ［3］ Boulaftali Y, Francois D, Venisse L, et al. Endothelial protease nexin1 is a novel regulator of A disintegrin and metalloproteinase 17 maturation and endothelial protein C receptor shedding via furin inhibition［J］. Arterioscler Thromb Vasc Biol, 2013, 33(7): 16471654. ［4］ Boulaftali Y, HoTinNoe B, Pena A, et al. Platelet protease nexin1, a serpin that strongly influences fibrinolysis and thrombolysis［J］. Circulation, 2011, 123(12): 13261334. ［5］ Bergeron S, Lemieux E, Durand V, et al. The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis［J］. Mol Cancer, 2010, 9: 271. ［6］ Binder BR, Mihaly J. The plasminogen activator inhibitor "paradox" in cancer［J］. Immunol Lett, 2008, 118(2): 116124. ［7］ Kwaan HC, Mazar AP, McMahon BJ. The apparent uPA/PAI1 paradox in cancer: more than meets the eye［J］. Semin Thromb Hemost, 2013, 39(4): 382391. ［8］ Iacoviello L, Agnoli C, De Curtis A, et al. Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study［J］. BMJ Open, 2013, 3(11): e003725. ［9］ Kim ER, Yang MH, Lim YJ, et al. Association between plasma levels of plasminogen activator inhibitor1 and colorectal neoplasms［J］. Gut Liver, 2013, 7(5): 519523. ［10］ Debucquoy A, Haustermans K, Daemen A, et al. Molecular response to cetuximab and efficacy of preoperative cetuximabbased chemoradiation in rectal cancer［J］. J Clin Oncol, 2009, 27(17): 27512757. ［11］ SelzerPlon J, Bornholdt J, Friis S, et al. Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis［J］. BMC Cancer, 2009, 9: 201. ［12］ Gao S, Krogdahl A, Sorensen JA, et al. Overexpression of protease nexin1 mRNA and protein in oral squamous cell carcinomas［J］. Oral Oncol, 2008, 44(3): 309313. ［13］ Nagahara A, Nakayama M, Oka D, et al. SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer［J］. Biochem Biophys Res Commun, 2010, 391(4): 16411646. ［14］ Fayard B, Bianchi F, Dey J, et al. The serine protease inhibitor protease nexin1 controls mammary cancer metastasis through LRP1mediated MMP9 expression［J］. Cancer Res, 2009, 69(14): 56905698. ［15］ Bianchini G, Qi Y, Alvarez RH, et al. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptorpositive and negative cancers［J］. J Clin Oncol, 2010, 28(28): 43164323. ［16］ McKee CM, Xu D, Cao Y, et al. Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma［J］. J Clin Invest, 2012, 122(11): 40254036. ［17］ McKee CM, Xu D, Muschel RJ. Protease nexin 1: a novel regulator of prostate cancer cell growth and neoangiogenesis［J］. Oncotarget, 2013, 4(1): 12. ［18］ Balsara RD, Ploplis VA. Plasminogen activator inhibitor1: the doubleedged sword in apoptosis［J］. Thromb Haemost, 2008, 100(6): 1029 1036. ［19］ Selbonne S, Azibani F, Iatmanen S, et al. In vitro and in vivo antiangiogenic properties of the serpin protease nexin1［J］. Mol Cell Biol, 2012, 32(8): 14961505. ［20］ Xu D, Suenaga N, Edelmann MJ, et al. Novel MMP9 substrates in cancer cells revealed by a labelfree quantitative proteomics approach［J］. Mol Cell Proteomics, 2008, 7(11): 22152228. ［21］ Xu D, McKee CM, Cao Y, et al. Matrix metalloproteinase9 regulates tumor cell invasion through cleavage of protease nexin1［J］. Cancer Res, 2010, 70(17): 69886998. ［22］ Zheng D, Chen H, Davids J, et al. Serpins for diagnosis and therapy in cancer［J］. Cardiovasc Hematol Disord Drug Targets, 2013, 13(2): 123132.

[1]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[2]	任露, 谢晓丽, 张坤, 王丽娟. 双氢青蒿素联合卡非佐米对多发性骨髓瘤细胞活性、增殖、凋亡的影响及机制研究[J]. 国际肿瘤学杂志, 2024, 51(3): 129-136.
[3]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵. 寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	张科平, 赵永生, 杨娟, 付茂勇. 绿原酸通过抑制PI3K-Akt信号通路诱导肺癌A549细胞线粒体功能障碍[J]. 国际肿瘤学杂志, 2024, 51(1): 21-28.
[6]	向玉玲, 谭佳杰, 熊远果, 赵丽蓉, 黎晨, 张洪. 脱水淫羊藿素对肝癌细胞增殖、迁移和凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(9): 513-519.
[7]	冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰. miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456.
[8]	张露, 蒋华, 林州, 马辰莺, 徐晓婷, 王利利, 周菊英. 免疫检查点抑制剂治疗复发转移性宫颈癌的疗效及预后分析[J]. 国际肿瘤学杂志, 2023, 50(8): 475-483.
[9]	吴佳丽, 张佳慧, 张萍, 肖昕悦, 李睿, 张红宇. Bcl-2 BH4选择性抑制剂BDA-366抑制NK/T细胞淋巴瘤细胞的机制研究[J]. 国际肿瘤学杂志, 2023, 50(7): 413-418.
[10]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平. GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[11]	杨丽蓉, 王羽丰. 预测浆液性卵巢癌术后复发远处转移风险机器学习模型的构建[J]. 国际肿瘤学杂志, 2023, 50(4): 220-226.
[12]	李雄安, 颜艳艳. 丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192.
[13]	马培晗, 张灵敏, 路宁, 张明鑫. 麻醉对肝细胞癌复发转移的影响[J]. 国际肿瘤学杂志, 2023, 50(2): 117-121.
[14]	朱易, 陈健. 硫化氢在肿瘤发生发展中的作用机制及其供体抗肿瘤作用[J]. 国际肿瘤学杂志, 2023, 50(12): 729-733.
[15]	吕璐, 孙鹏飞, 崔腾璐. 子宫内膜癌颈部淋巴结转移综合治疗1例并文献复习[J]. 国际肿瘤学杂志, 2023, 50(11): 701-704.